Table 2.
Alport syndrome disease progression in this trial.
| Progression | Definition |
|---|---|
| Stage 0 to I | Albuminuria >30 mg albumin/gCrea in combination with a 3-fold increase from baseline in albuminuria, confirmed within 2 weeks. |
| Stage I to II | (i) Twofold increase from baseline albuminuria, confirmed within 2 weeks |
| (ii) Albuminuria >300 mg albumin/gCrea at a single assessment. |